Insights into the conformation and self-association of a concentrated monoclonal antibody using isothermal chemical denaturation and nuclear magnetic resonance

| GregoryGregory | 0 Comment
Insights into the conformation and self-association of a concentrated monoclonal antibody using isothermal chemical denaturation and nuclear magnetic resonance
The aim of this investigation was to spotlight the utility of nuclear magnetic resonance (NMR) as a multi-attribute methodology for the characterization of therapeutic antibodies. On this case examine, we in contrast outcomes from isothermal chemical denaturation (ICD) and NMR with commonplace strategies to narrate conformational states of a mannequin monoclonal antibody (mAb1) with protein-protein interactions (PPI) that result in self – affiliation in concentrated options.
The rise in aggregation fee and relative viscosity for mAb1 was discovered to be each focus and pH dependent. The free vitality of unfolding (∆G⁰) from ICD and thermal evaluation in dilute options indicated that though the native state predominated between pH 4 – pH 7, it was disrupted on the CH2 and unfolded noncooperatively underneath acidic situations.
One-dimensional (1D) 1H NMR and two-dimensional (2D) 13C-1H NMR carried out, in concentrated options, confirmed that PPI between pH 4 – 7 occurred whereas mAb1 was within the native state. NMR corroborated that mAb1 maintained a dominant native state at formulation-relevant situations on the examined pH vary, had elevated world molecular tumbling dynamics at decrease pH and confirmed elevated PPI at larger pH situations.
This report aligns and compares typical characterization of an IgG1 with evaluation of construction by NMR and supplied a extra exact evaluation and deeper perception into the conformation of an IgG1 in concentrated options.

Elevated mycobacterium avium subsp. paratuberculosis (MAP) antibody titer in Japanese a number of sclerosis

To research whether or not antibody manufacturing in opposition to mycobacterium avium subsp. paratuberculosis (MAP) is said to scientific traits of a number of sclerosis (MS) and human leukocyte antigen (HLA) alleles, IgG antibody in opposition to three MAP peptides and two human peptides homologous to MAP had been measured in sera from 103 MS sufferers and 50 wholesome controls (HCs).
MS sufferers had larger IgG ranges in opposition to MAP2694295-303 (MAP2694-IgG) than HCs, whereas the opposite antibodies had been comparable. Multivariate evaluation demonstrated that larger MAP2694-IgG titers had been related to larger EDSS scores, however not with HLA alleles or dairy product consumption. Immune response in opposition to MAP could worsen MS incapacity.

Predominant mesangial IgM, C3, and λ gentle chain depositions and interstitial nephritis in a affected person with overlap syndrome and positivity for anti-mitochondrial M2 antibody: a case report

Overlap syndrome refers to a gaggle of situations which have scientific options of a couple of well-characterised rheumatic illness and meet the respective classification standards. There aren’t any typical renal histological findings in overlap syndrome. When sufferers with overlap syndrome develop renal dysfunction, varied potential causes, together with lupus nephritis (LN), renal disaster by systemic sclerosis, interstitial nephritis, and so forth, should be distinguished.
Right here, we report a 44-year-old lady with overlap syndrome involving systemic lupus erythematosus (SLE), diffuse cutaneous systemic scleroderma, and Sjogren’s syndrome, who was additionally optimistic for anti-mitochondrial M2 antibody. She developed glomerular haematuria, proteinuria, and enhance in creatinine appeared regularly.
Suspecting LN, renal biopsy was carried out. Nonetheless, within the interstitium, gentle infiltration of lymphocytes and plasma cells and really partial fibrosis had been noticed. Immunofluorescence microscopy revealed predominant mesangial immunoglobulin M, C3, and λ gentle chain staining. General, LN was not recognized primarily based on these findings.
Renal dysfunction was normalised by glucocorticoid remedy for three months. This case suggests the significance of a renal analysis primarily based on renal pathological findings, particularly in a case of overlap syndrome together with SLE.

A Japanese Affected person with Anti-PM/Scl and Centromere Antibody-Constructive Scleroderma-Amyopathic Dermatomyositis Overlap Syndrome Who Developed Renal Disaster

Anti-PM/Scl antibodies are related to the overlap syndrome of systemic sclerosis and dermatomyositis/polymyositis (SSc-DM/PM), and are present in 50% of SSc-DM/PM instances in Europe and the USA, whereas they’re uncommon in Japan. We report a case of an 80-year-old Japanese feminine with SSc-amyopathic dermatomyositis (ADM) overlap syndrome, who developed scleroderma renal disaster (SRC), a complication of SSc.
She had optimistic antinuclear antibodies in a discrete-speckled and nucleolar sample and anticentromere antibodies and anti-PM/Scl antibodies had been confirmed by ELISA and immunoprecipitation, respectively. The incidence fee of SRC in SSc sufferers varies considerably relying on the specificity of autoantibodies, with the very best incidence of ~50% in anti-RNA polymerase III antibody optimistic sufferers, adopted by ~10% in anti-PM/Scl and decrease incidence of 0.45% in anticentromere antibody-positive instances.
Anti-PM/Scl antibodies are unusual in Japanese sufferers presumably because of its robust affiliation with sure HLA haplotype that’s uncommon in Japanese. Scientific significance of anti-PM/Scl antibodies in Japanese sufferers will should be clarified with accumulation of instances in future research.

Intrinsic physicochemical profile of marketed antibody-based biotherapeutics

Feeding biopharma pipelines with biotherapeutic candidates that possess fascinating developability profiles will help enhance the productiveness of biologic drug discovery and improvement. Right here, we’ve got derived an in silico profile by analyzing computed physicochemical descriptors for the variable areas (Fv) present in 77 marketed antibody-based biotherapeutics. Fv areas of those biotherapeutics show vital diversities of their germlines, complementarity figuring out area loop lengths, hydrophobicity, and cost distributions.
Moreover, an evaluation of 24 physicochemical descriptors, calculated utilizing homology-based molecular fashions, has yielded 5 nonredundant descriptors whose distributions symbolize stability, isoelectric level, and molecular floor traits of their Fv areas. Fv areas of candidates from our inner discovery campaigns, human next-generation sequencing repertoires, and people in clinical-stages (CST) had been assessed for similarity with the physicochemical profile derived right here.
The Fv areas in 33% of CST antibodies present physicochemical properties which are dissimilar to presently marketed biotherapeutics. As compared, physicochemical traits of ∼29% of the Fv areas in human antibodies and ∼27% of our inner hits deviated considerably from these of marketed biotherapeutics.

CD146 Antibody
20-abx242914
  • EUR 560.40
  • EUR 393.60
  • 100 ul
  • 50 ul

CD146 antibody
10R-6489 100 ug
EUR 249.6
Description: Mouse monoclonal CD146 antibody

CD146 antibody
70R-14273 100 ug
EUR 386.4
Description: Affinity purified Mouse polyclonal CD146 antibody

CD146 Antibody
49868-100ul 100ul
EUR 399.6

CD146 Antibody
49868-50ul 50ul
EUR 286.8

CD146 Antibody
R20269-0.1ML 100ul
EUR 347.65
Description: This recombinant CD146 antibody reacts to human CD146 (Cell surface glycoprotein MUC18). It may also react to the mouse and rat protein, as predicted by immunogen homology.

CD146 Antibody
R30152 100 ug
EUR 356.15
Description: CD146 (cluster of differentiation 146), also known as MCAM and MUC18, is a cell adhesion molecule used as a marker for endothelial cell lineage. CD146 has been demonstrated to appear on a small subset of T and B lymphocytes in the peripheral blood of healthy individuals. It has been seen as a marker for mesenchymal stem cells isolated from multiple adult and fetal organs, and its expression may be linked to multipotency mesenchymal stem cells with greater differentiation potential express higher levels of CD146 on the cell surface.

CD146 Antibody (FITC)
abx200496-100tests 100 tests
EUR 477.6

MCAM(CD146) Antibody
48005-100ul 100ul
EUR 399.6

MCAM(CD146) Antibody
48005-50ul 50ul
EUR 286.8

CD146 Antibody (Biotin)
abx200500-100ug 100 ug
EUR 460.8

CD146 antibody (biotin)
61R-CD146aHUBT 100 tests
EUR 625.2
Description: Mouse monoclonal CD146 antibody (biotin)

CD146 Conjugated Antibody
C49868 100ul
EUR 476.4

Anti-Hu CD146 PE
1P-783-T025 25 tests
EUR 168

Anti-Hu CD146 PE
1P-783-T100 100 tests
EUR 288

CD146/MCAM Antibody (CT)
6801-100 each
EUR 379.2

Anti-Hu CD146 Purified
11-783-C025 0.025 mg
EUR 118.8

Anti-Hu CD146 Purified
11-783-C100 0.1 mg
EUR 189.6

anti- CD146/MCAM antibody
FNab01428 100µg
EUR 606.3
Description: Antibody raised against CD146/MCAM

anti- CD146/MCAM antibody
FNab01429 100µg
EUR 702
Description: Antibody raised against CD146/MCAM

CD146 Antibody / MCAM / MUC18
RQ5661 100 ug
EUR 356.15
Description: CD146 (cluster of differentiation 146), also known as the melanoma cell adhesion molecule (MCAM) or cell surface glycoprotein MUC18, is a 113kDa cell adhesion molecule currently used as a marker for endothelial cell lineage. MCAM, a member of the immunoglobulin superfamily, is homologous to several cell adhesion molecules and is associated with tumor progression and the development of metastasis in human malignant melanoma. By radiation hybrid analysis, this gene is mapped to chromosome 11q23.3. MCAM has been demonstrated to appear on a small subset of T and B lymphocytes in the peripheral blood of healthy individuals. MCAM has been seen as a marker for mesenchymal stem cells isolated from multiple adult and fetal organs, and its expression may be linked to multipotency mesenchymal stem cells with greater differentiation potential express higher levels of MCAM on the cell surface.

CD146 Antibody / MCAM / MUC18
RQ5939 100 ug
EUR 356.15
Description: CD146 (cluster of differentiation 146), also known as the melanoma cell adhesion molecule (MCAM) or cell surface glycoprotein MUC18, is a 113kDa cell adhesion molecule currently used as a marker for endothelial cell lineage. MCAM, a member of the immunoglobulin superfamily, is homologous to several cell adhesion molecules and is associated with tumor progression and the development of metastasis in human malignant melanoma. By radiation hybrid analysis, this gene is mapped to chromosome 11q23.3. MCAM has been demonstrated to appear on a small subset of T and B lymphocytes in the peripheral blood of healthy individuals. MCAM has been seen as a marker for mesenchymal stem cells isolated from multiple adult and fetal organs, and its expression may be linked to multipotency mesenchymal stem cells with greater differentiation potential express higher levels of MCAM on the cell surface.

Cd146 Antibody / MCAM / MUC18
RQ5987 100 ug
EUR 356.15
Description: In humans, the CD146 protein is encoded by the MCAM gene. It is mapped to 9; 9 A5.1. CD146 (cluster of differentiation 146) also known as the melanoma cell adhesion molecule (MCAM) or cell surface glycoprotein MUC18, is a 113kDa cell adhesion molecule currently used as a marker for endothelial cell lineage. MCAM functions as a receptor for laminin alpha 4, a matrix molecule that is broadly expressed within the vascular wall. Accordingly, MCAM is highly expressed by cells that are components of the blood vessel wall, including vascular endothelial cells, smooth muscle cells and pericytes. Its function is still poorly understood, but evidence points to it being part of the endothelial junction associated with the actin cytoskeleton. A member of the Immunoglobulin superfamily, it consists of five Ig domains, a transmembrane domain, and a cytoplasmic region. It is expressed on chicken embryonic spleen and thymus, activated human T cells, endothelial progenitors such as angioblasts and mesenchymal stem cells, and strongly expressed on blood vessel endothelium and smooth muscle.

CD146 Antibody / MCAM / MUC18
V3638-100UG 100 ug
EUR 349.3
Description: CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V3638-20UG 20 ug
EUR 153.3
Description: CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V3638IHC-7ML 7 ml
EUR 349.3
Description: CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V3638SAF-100UG 100 ug
EUR 349.3
Description: CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V8923-100UG 100ug
EUR 349.3
Description: The human MCAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated Mel-CAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MCAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V8923-20UG 20ug
EUR 153.3
Description: The human MCAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated Mel-CAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MCAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V8923SAF-100UG 100ug
EUR 349.3
Description: The human MCAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated Mel-CAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MCAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V7138-100UG 100 ug
EUR 349.3
Description: CD146/MUC18/MCAM plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration. [UniProt]

CD146 Antibody / MCAM / MUC18
V7138-20UG 20 ug
EUR 153.3
Description: CD146/MUC18/MCAM plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration. [UniProt]

CD146 Antibody / MCAM / MUC18
V7138IHC-7ML 7 ml
EUR 349.3
Description: CD146/MUC18/MCAM plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration. [UniProt]

CD146 Antibody / MCAM / MUC18
V7138SAF-100UG 100 ug
EUR 349.3
Description: CD146/MUC18/MCAM plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration. [UniProt]

CD146 Antibody / MCAM / MUC18
V2696-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2696-20UG 20 ug
EUR 153.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2696IHC-7ML 7 ml
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2696SAF-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2697-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2697-20UG 20 ug
EUR 153.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2697IHC-7ML 7 ml
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2697SAF-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2698-100UG 100 ug
EUR 349.3
Description: The human CD146 gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2698-20UG 20 ug
EUR 153.3
Description: The human CD146 gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2698IHC-7ML 7 ml
EUR 349.3
Description: The human CD146 gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2698SAF-100UG 100 ug
EUR 349.3
Description: The human CD146 gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2699-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2699-20UG 20 ug
EUR 153.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2699IHC-7ML 7 ml
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2699SAF-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2189-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MUC18 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MUC18 / CD146 is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2189-20UG 20 ug
EUR 153.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MUC18 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MUC18 / CD146 is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V2189SAF-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MUC18 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MUC18 / CD146 is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V7942-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V7942-20UG 20 ug
EUR 153.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V7942SAF-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V7943-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V7943-20UG 20 ug
EUR 153.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

CD146 Antibody / MCAM / MUC18
V7943SAF-100UG 100 ug
EUR 349.3
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease.

MCAM(CD146) Conjugated Antibody
C48005 100ul
EUR 476.4

CD146 Monoclonal Antibody [RMC563A]
A68401
  • EUR 754.26
  • EUR 350.90
  • EUR 470.80
  • 100 µl
  • 50 ul
  • 100 ul

CD146 recombinant monoclonal antibody
A5098 100ul X 3
EUR 714
Description: A recombinant monoclonal antibody from rabbit against human CD146 for WB, IF,ELISA

Anti-MCAM / CD146/ MUC18 antibody
STJ73585 100 µg
EUR 430.8

Polyclonal CD146/MCAM Antibody (CT)
APR00368G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD146/MCAM (CT). This antibody is tested and proven to work in the following applications:

Recombinant Human CD146/MCAM Protein
RP00101 20 μg
EUR 448.8

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCA0676-250 250uL
EUR 459.6
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), APC conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC800676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF680 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC800676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF680 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC810676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF680R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC810676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF680R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC940676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF594 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC940676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF594 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC700676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF770 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC700676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF770 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC880676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF488A conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC880676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF488A conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC050676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF405M conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC050676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF405M conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC040676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF405S conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC040676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF405S conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC400676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF640R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC400676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF640R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCB0676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Biotin conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCB0676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Biotin conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCAP0676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCAP0676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCR0676-250 250uL
EUR 459.6
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), RPE conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCP0676-250 250uL
EUR 459.6
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), PerCP conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNUM0676-50 50uL
EUR 474
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), 1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCH0676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNCH0676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNUB0676-100 100uL
EUR 250.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Concentration: 0.2mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNUB0676-500 500uL
EUR 549.6
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Concentration: 0.2mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC550676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF555 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC550676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF555 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC610676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF660R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC610676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF660R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC470676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF647 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC470676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF647 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC430676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF543 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC430676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF543 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC680676-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF568 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(OJ79c) Antibody
BNC680676-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF568 conjugate, Concentration: 0.1mg/mL

Human MCAM/CD146 PicoKine ELISA Kit
EK1675 96 wells
EUR 510
Description: For Quantitative Detection of human MCAM in cell culture supernates and serum.

Cell Surface Glycoprotein MUC18 (CD146) Antibody
abx200495-100ug 100 ug
EUR 393.6

Cell Surface Glycoprotein MUC18 (CD146) Antibody
abx231428-100ug 100 ug
EUR 577.2

Cell Surface Glycoprotein MUC18 (CD146) Antibody
abx231429-100ug 100 ug
EUR 661.2

Cell Surface Glycoprotein MUC18 (CD146) Antibody
20-abx225287
  • EUR 444.00
  • EUR 727.20
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 50 ul

Cell Surface Glycoprotein MUC18 (CD146) Antibody
abx139732-01mg 0.1 mg
EUR 427.2

Cell Surface Glycoprotein MUC18 (CD146) Antibody
abx019043-100ug 100 ug
EUR 410.4

Cell Surface Glycoprotein MUC18 (CD146) Antibody
abx413746-02mg 0.2 mg
EUR 678

Cell Surface Glycoprotein MUC18 (CD146) Antibody
abx413749-25ug 25 ug
EUR 326.4

Cell Surface Glycoprotein MUC18 (CD146) Antibody
abx413750-1mg 1 mg
EUR 994.8

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC941130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF594 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC941130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF594 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC801130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF680 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC801130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF680 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC811130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF680R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC811130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF680R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC701130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF770 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC701130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF770 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC881130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF488A conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC881130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF488A conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC051130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF405M conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC051130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF405M conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC041130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF405S conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC041130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF405S conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC401130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF640R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC401130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF640R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCB1130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Biotin conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCB1130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Biotin conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCAP1130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCAP1130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCA1130-250 250uL
EUR 459.6
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), APC conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCR1130-250 250uL
EUR 459.6
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), RPE conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCP1130-250 250uL
EUR 459.6
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), PerCP conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNUM1130-50 50uL
EUR 474
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), 1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCH1130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNCH1130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNUB1130-100 100uL
EUR 250.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Concentration: 0.2mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNUB1130-500 500uL
EUR 549.6
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Concentration: 0.2mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC611130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF660R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC611130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF660R conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC551130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF555 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC551130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF555 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC431130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF543 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC431130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF543 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC681130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF568 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC681130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF568 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC471130-100 100uL
EUR 238.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF647 conjugate, Concentration: 0.1mg/mL

MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody
BNC471130-500 500uL
EUR 652.8
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF647 conjugate, Concentration: 0.1mg/mL

Cell Surface Glycoprotein MUC18 (CD146) Antibody (PE)
abx200497-100tests 100 tests
EUR 543.6

Cell Surface Glycoprotein MUC18 (CD146) Antibody (PE)
abx139733-100tests 100 tests
EUR 577.2

Cell Surface Glycoprotein MUC18 (CD146) Antibody (APC)
abx200498-100tests 100 tests
EUR 543.6

Cell Surface Glycoprotein MUC18 (CD146) Antibody (FITC)
abx413747-01mg 0.1 mg
EUR 693.6
The early availability of this data will help information hit choice, lead identification, and optimization of biotherapeutic candidates. Insights from this work can even assist help portfolio threat evaluation, in-licensing, and biopharma collaborations.
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.

Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.

To enhance our understanding of properties that confer profitable inhibition of chemokines in vivo, we analyzed anti-murine CXCL10 monoclonal antibodies (mAb) having totally different traits. 1B6 displayed potent inhibition of

READ MOREREAD MORE